Publication | Closed Access

Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus

Metabolic SyndromeInsulin SignalingDiabetes ManagementSignal TransductionMedicineLiver PhysiologyDiabetesImmunologyPrevents DevelopmentDiabetes ComplicationsReceptor ActivatorDiabetes MellitusMetabolic SignalingPharmacologyCell SignalingHealth Sciences